The manufacturer of Arcoxia received a non-approvalable letter from the FDA in April of 2007. This non-approvable letter was due to safety concerns of an increasedArcoxia is used for the following: acute and chronic treatment of the signs and symptoms of osteoarthritis and rheumatoid arthritis....